Mydecine Innovations Group ($MYCO | $MYCOF | $0NFA) closed their acquisition of NeuroPharm Inc. in an all-share transaction valued at $6.3M. Mydecine also announced that its shareholders have agreed to extend lock up restrictions on over 35M shares for an additional 120 days. Mydecine News |
|